Todd Watanabe
Algemeen Directeur bij ARCUTIS BIOTHERAPEUTICS, INC.
Vermogen: 9 M $ op 30-04-2024
Actieve functies van Todd Watanabe
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Directeur/Bestuurslid | 01-01-2016 | - |
| Algemeen Directeur | 01-04-2017 | - | |
| President | 01-01-2016 | - | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Directeur/Bestuurslid | 23-06-2021 | - |
Loopbaan van Todd Watanabe
Eerdere bekende functies van Todd Watanabe
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Kanan Therapeutics, Inc. | Operationeel Directeur | 01-12-2015 | 01-02-2018 |
| Oprichter | 01-12-2015 | 01-02-2018 | |
| KYTHERA BIOPHARMACEUTICALS INC | Corporate Officer/Principal | 01-10-2013 | 01-11-2015 |
Opleiding van Todd Watanabe
| Georgetown University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
| Kanan Therapeutics, Inc. | |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Health Technology |
- Beurs
- Insiders
- Todd Watanabe
- Ervaring